Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid oligomers: I. Synthesis and characterization.

A series of oligomers or low molecular weight polymers of lactic and/or glycolic acid has been synthesized with different molar ratios of lactic to glycolic acid. These oligomers have been characterized with respect to oligomer composition, molecular weight, intrinsic viscosity, crystallinity, melting temperature, and glass transition temperature. The polymerization conditions for the lactic/glycolic acid oligomer syntheses were as follows: 180-220 degrees C, 5 mm Hg, 5 h, and 0.1 wt% of catalyst (antimony oxide) concentration. The polymeric compositions correlated to the feed ratios of lactic to glycolic acid. The molecular weight of the oligomers ranged from 895.8 +/- 48.7 to 1368.0 +/- 0 D with the intrinsic viscosity ranging from 0.0513 to 0.0814 dl g-1. The lactic/glycolic acid oligomers were found to be amorphous. The glass transition temperatures of the lactic/glycolic acid oligomers were lower than physiological temperature.

[1]  G. Marom,et al.  Amorphous and crystalline morphologies in glycolic acid and lactic acid polymers , 1987 .

[2]  H. Okada,et al.  Controlled-release of leuprolide acetate from polylactic acid or copoly(lactic/glycolic) acid microcapsules: influence of molecular weight and copolymer ratio of polymer. , 1988, Chemical & pharmaceutical bulletin.

[3]  J. Kohn,et al.  Trends in the Development of Bioresorbable Polymers for Medical Applications , 1992, Journal of Biomaterials Applications.

[4]  F. Hutchinson,et al.  Biodegradable polymer systems for the sustained release of polypeptides , 1990 .

[5]  G. E. Visscher,et al.  Enhancing Drug Release from Polylactide Microspheres by Using Base in the Microencapsulation Process , 1987 .

[6]  Albert J. Pennings,et al.  SYNTHESIS OF HIGH-MOLECULAR-WEIGHT POLY(L-LACTIDE) INITIATED WITH TIN 2-ETHYLHEXANOATE , 1987 .

[7]  H. Yamanaka,et al.  Biodegradability of a hot-pressed poly(lactic acid) formulation with controlled release of LH-RH agonist and its pharmacological influence on rat prostate , 1985 .

[8]  Y Ikada,et al.  Synthesis of polylactides with different molecular weights. , 1997, Biomaterials.

[9]  B.J.A. Furra,et al.  A biodegradable delivery system for peptides: preclinical experience with the gonadotrophin-releasing hormone agonist Zoladex☆ , 1992 .

[10]  J. Feijen,et al.  The ring‐opening polymerization of D,L‐lactide in the melt initiated with tetraphenyltin , 1984 .

[11]  E. J. Frazza,et al.  A new absorbable suture. , 1971, Journal of biomedical materials research.

[12]  Yoshito Ikada,et al.  Thermal characterization of polylactides , 1988 .

[13]  X. Wu,et al.  Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid oligomers: Part II. Biodegradation and drug delivery application. , 1997, Journal of biomaterials science. Polymer edition.

[14]  Charles J. Pouchert.  The Aldrich library of FT-IR spectra , 1985 .

[15]  A. U. Daniels,et al.  Mechanical properties of biodegradable polymers and composites proposed for internal fixation of bone. , 1990, Journal of applied biomaterials : an official journal of the Society for Biomaterials.

[16]  Ross R. Muth,et al.  Biodegradable polymers for use in surgery—polyglycolic/poly(actic acid) homo- and copolymers: 1 , 1979 .

[17]  C. Chu.  An in-vitro study of the effect of buffer on the degradation of poly(glycolic acid) sutures. , 1981, Journal of biomedical materials research.

[18]  J. Benoit,et al.  Formation and characterization of cisplatin loaded poly(d,l-lactide) microspheres for chemoembolization. , 1986, Journal of pharmaceutical sciences.

[19]  Donald L. Wise,et al.  Encyclopedic Handbook of Biomaterials and Bioengineering , 1995 .

[20]  G. Entenmann,et al.  Resorbable polyesters: composition, properties, applications. , 1992, Clinical materials.

[21]  J. Benoit,et al.  In vitro and in vivo degradation of poly(D,L lactide/glycolide) type microspheres made by solvent evaporation method. , 1989, Biomaterials.

[22]  H. Okada,et al.  One-month release injectable microcapsules of a luteinizing hormone-releasing hormone agonist (leuprolide acetate) for treating experimental endometriosis in rats. , 1988, The Journal of pharmacology and experimental therapeutics.

[23]  M. Alonso,et al.  Development of biodegradable microspheres and nanospheres for the controlled release of cyclosporin A , 1993 .

[24]  J Nieuwenhuis,et al.  Synthesis of polylactides, polyglycolides and their copolymers. , 1992, Clinical materials.